Pharmac's record funding-boost will address the fiscal cliff it faces.\xa0
An additional $1.7 billion spread over four-years has been ear-marked for the drug-buying agency in the upcoming Budget.\xa0
Chief Executive Sarah Fitt told Mike Hosking that the extra cash covers time-limited funding for some treatments, which ends this year.\xa0
She says the fiscal hole was always known, as the funds outlined in Budget 2022 only went through to Budget 2024.\xa0
LISTEN ABOVE\xa0\xa0\xa0
See omnystudio.com/listener for privacy information.